Segluromet

Active Ingredient(s): Ertugliflozin + Metformin Hydrochloride
FDA Approved: * December 19, 2017
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Segluromet Overview

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes,[6][7] particularly in people who are overweight.[8] It is also used in the treatment of polycystic ovary syndrome.[6] It is not associated with weight gain.[9] It is taken by mouth.[6] Metformin is generally well tolerated.[10] Common adverse effects i...

Read more Segluromet Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metformin

Recent Segluromet Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ertugliflozin + Metformin Hydrochloride
  • Tablet: 2.5mg + 1gm, 2.5mg + 500mg, 7.5mg + 1gm, 7.5mg + 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Segluromet: (4 results)

Sorted by National Drug Code
  • 0006-5369 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5370 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5373 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5374 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Drugs with one or more similar ingredients: (30 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA